Source: Business Wire

Press Release: Avid Radiopharmaceuticals : Market Report for PET Imaging in Japan - Market Analysis & Future Developments - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Market Report for PET Imaging in Japan" report to their offering. In Japan PET scanners were introduced in the 1990's and the PET cancer screening program was first investigated in 1994, becoming fully established in 2002. This program promoted the widespread use of PET machines and the number of PET facilities in Japan has remarkably increased over the last decade. Currently, Japan is the only country in which PET

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
100-250
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



Avid Radiopharmaceuticals, Inc., is a Private company. Avid Radiopharmaceuticals, Inc.,'s parent company has been Lilly Eli & Co since Dec 2011.